These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 26595550)

  • 1. Changes in the Abundance of Faecalibacterium prausnitzii Phylogroups I and II in the Intestinal Mucosa of Inflammatory Bowel Disease and Patients with Colorectal Cancer.
    Lopez-Siles M; Martinez-Medina M; Surís-Valls R; Aldeguer X; Sabat-Mir M; Duncan SH; Flint HJ; Garcia-Gil LJ
    Inflamm Bowel Dis; 2016 Jan; 22(1):28-41. PubMed ID: 26595550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in the Abundance and Co-occurrence of
    Lopez-Siles M; Enrich-Capó N; Aldeguer X; Sabat-Mir M; Duncan SH; Garcia-Gil LJ; Martinez-Medina M
    Front Cell Infect Microbiol; 2018; 8():281. PubMed ID: 30245977
    [No Abstract]   [Full Text] [Related]  

  • 3. Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes.
    Lopez-Siles M; Martinez-Medina M; Busquets D; Sabat-Mir M; Duncan SH; Flint HJ; Aldeguer X; Garcia-Gil LJ
    Int J Med Microbiol; 2014 May; 304(3-4):464-75. PubMed ID: 24713205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosa-associated Faecalibacterium prausnitzii phylotype richness is reduced in patients with inflammatory bowel disease.
    Lopez-Siles M; Martinez-Medina M; Abellà C; Busquets D; Sabat-Mir M; Duncan SH; Aldeguer X; Flint HJ; Garcia-Gil LJ
    Appl Environ Microbiol; 2015 Nov; 81(21):7582-92. PubMed ID: 26296733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of bacterial biomarkers to aid in challenging inflammatory bowel diseases diagnostics and subtype classification.
    Lopez-Siles M; Aldeguer X; Sabat-Mir M; Serra-Pagès M; Duncan SH; Flint HJ; Garcia-Gil LJ; Martinez-Medina M
    World J Gastrointest Pathophysiol; 2020 May; 11(3):64-77. PubMed ID: 32435523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar Depletion of Protective Faecalibacterium prausnitzii in Psoriasis and Inflammatory Bowel Disease, but not in Hidradenitis Suppurativa.
    Eppinga H; Sperna Weiland CJ; Thio HB; van der Woude CJ; Nijsten TE; Peppelenbosch MP; Konstantinov SR
    J Crohns Colitis; 2016 Sep; 10(9):1067-75. PubMed ID: 26971052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low counts of Faecalibacterium prausnitzii in colitis microbiota.
    Sokol H; Seksik P; Furet JP; Firmesse O; Nion-Larmurier I; Beaugerie L; Cosnes J; Corthier G; Marteau P; Doré J
    Inflamm Bowel Dis; 2009 Aug; 15(8):1183-9. PubMed ID: 19235886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis.
    Varela E; Manichanh C; Gallart M; Torrejón A; Borruel N; Casellas F; Guarner F; Antolin M
    Aliment Pharmacol Ther; 2013 Jul; 38(2):151-61. PubMed ID: 23725320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics.
    Lopez-Siles M; Duncan SH; Garcia-Gil LJ; Martinez-Medina M
    ISME J; 2017 Apr; 11(4):841-852. PubMed ID: 28045459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review and meta-analysis of the role of Faecalibacterium prausnitzii alteration in inflammatory bowel disease.
    Zhao H; Xu H; Chen S; He J; Zhou Y; Nie Y
    J Gastroenterol Hepatol; 2021 Feb; 36(2):320-328. PubMed ID: 32815163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease.
    Fujimoto T; Imaeda H; Takahashi K; Kasumi E; Bamba S; Fujiyama Y; Andoh A
    J Gastroenterol Hepatol; 2013 Apr; 28(4):613-9. PubMed ID: 23216550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease.
    Willing B; Halfvarson J; Dicksved J; Rosenquist M; Järnerot G; Engstrand L; Tysk C; Jansson JK
    Inflamm Bowel Dis; 2009 May; 15(5):653-60. PubMed ID: 19023901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First steps towards combining faecal immunochemical testing with the gut microbiome in colorectal cancer screening.
    Grobbee EJ; Lam SY; Fuhler GM; Blakaj B; Konstantinov SR; Bruno MJ; Peppelenbosch MP; Kuipers EJ; Spaander MC
    United European Gastroenterol J; 2020 Apr; 8(3):293-302. PubMed ID: 32213018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cultured representatives of two major phylogroups of human colonic Faecalibacterium prausnitzii can utilize pectin, uronic acids, and host-derived substrates for growth.
    Lopez-Siles M; Khan TM; Duncan SH; Harmsen HJ; Garcia-Gil LJ; Flint HJ
    Appl Environ Microbiol; 2012 Jan; 78(2):420-8. PubMed ID: 22101049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumour Necrosis Factor Treatment with Adalimumab Induces Changes in the Microbiota of Crohn's Disease.
    Busquets D; Mas-de-Xaxars T; López-Siles M; Martínez-Medina M; Bahí A; Sàbat M; Louvriex R; Miquel-Cusachs JO; Garcia-Gil JL; Aldeguer X
    J Crohns Colitis; 2015 Oct; 9(10):899-906. PubMed ID: 26142465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis.
    Hansen R; Russell RK; Reiff C; Louis P; McIntosh F; Berry SH; Mukhopadhya I; Bisset WM; Barclay AR; Bishop J; Flynn DM; McGrogan P; Loganathan S; Mahdi G; Flint HJ; El-Omar EM; Hold GL
    Am J Gastroenterol; 2012 Dec; 107(12):1913-22. PubMed ID: 23044767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease?
    Jia W; Whitehead RN; Griffiths L; Dawson C; Waring RH; Ramsden DB; Hunter JO; Cole JA
    FEMS Microbiol Lett; 2010 Sep; 310(2):138-44. PubMed ID: 20695899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Analyses of Gut-Associated Bacterial Microbiota in Ulcerative Colitis Patients.
    Al-Bayati L; Nayeri Fasaei B; Merat S; Bahonar A
    Arch Iran Med; 2018 Dec; 21(12):578-584. PubMed ID: 30634855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CCR6 and CXCR6 by Gut-Derived CD4
    Godefroy E; Alameddine J; Montassier E; Mathé J; Desfrançois-Noël J; Marec N; Bossard C; Jarry A; Bridonneau C; Le Roy A; Sarrabayrouse G; Kerdreux E; Bourreille A; Sokol H; Jotereau F; Altare F
    Gastroenterology; 2018 Oct; 155(4):1205-1217. PubMed ID: 29981781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Specificity comparison of three Feacalibacterium prausnitzii-specific PCR primer pairs].
    Feng J; Hua W; Zhao L; Zhao Y; Shen J
    Wei Sheng Wu Xue Bao; 2011 Jun; 51(6):819-27. PubMed ID: 21866708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.